IPO Trending
CBPLSME / BSEListed

Chandra Bhagat Pharma Limited

Chandra Bhagat Pharma Limited, established in 2003, is engaged in marketing lifesaving medicines in India across therapeutic areas such as cardiovascular care, cancer treatment, antibiotics, hormones, anesthesia, pediatrics, nephrology, antiviral, antifungal, and neurology. The company operates under its own brand with the support of an in-house sales team and distribution network that supplies healthcare centers and hospitals, while also dealing in specialty chemicals. In addition to finished formulations, it imports, supplies, and undertakes indenting of active pharmaceutical ingredients and intermediates, and holds FDA approval to manufacture formulations through contract manufacturers. Its storage facilities are located on a leased basis in Bhiwandi, Thane, Maharashtra, and the company also exports pharmaceutical products to international markets including DR Congo, Bolivia, and the Philippines.

₹51 - ₹51Open
Listed Price51.70
Listing Gain+1.37%
Review-Analyst Consensus Verdict

May apply

No review summary is available yet.

Apply
00%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
No IPO review records are available for this issue yet.